HAUPPAUGE, N.Y. - (BUSINESS WIRE)- June 10, 2003 - Curative Health Services, Inc., (Nasdaq: CURE), announced the completion of a new $35 million senior secured credit facility with GE Healthcare Financial Services, including a $15 million revolver and a $20 million term loan, which replaces the Company's existing line of credit.

The new credit facility matures on June 9, 2008 and bears interest at variable rates equal to LIBOR plus a margin ranging from 3% to 4%. The new facility will be expandable for acquisitions, subject to conditions, for an additional $45 million. As previously discussed, it is anticipated that there will be a charge of $0.03 - $0.04 per diluted share related to terminating the Company's existing credit facility.

Joseph Feshbach, Curative's Chairman and Chief Executive Officer, commented on the new agreement. "We are very pleased to enter into this relationship with GE Healthcare Financial Services. The completion of this credit facility provides Curative with additional resources to support the expansion of our Specialty Pharmacy Services business both organically and through further acquisitions."

About Curative Health Services

Curative Health Services delivers superior clinical outcomes and unmatched patient satisfaction for patients experiencing serious medical conditions through two unique business units.

Curative's Specialty Pharmacy Services business unit provides services to help patients manage the health care process, and offers related pharmacy products to patients for chronic and critical disease states including Hemophilia, Immune System Disorders, Respiratory Syncytial Virus (RSV), Multiple Sclerosis and Rheumatoid Arthritis.

Curative's Specialty Healthcare Services ("SHS") business unit is an industry leader in chronic wound care management, consistently achieving an outcome success rate of more than 85 percent. SHS provides a broad continuum of services to health care providers through a nationwide network. This national network of hospital-based Wound Care Center(R) programs has offered comprehensive treatment to over 375,000 patients, achieving more than a 94 percent patient satisfaction rate.

For more information, visit www.curative.com

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors that might cause such differences include, but are not limited to, the termination or non-renewal of a material number of contracts, an inability to obtain new contracts, changes in the government regulations relating to the Company's Specialty Healthcare Services or Specialty Pharmacy Services business units, changes in the regulations governing third party reimbursements for the Company's services, manufacturing shortages of products sold by Curative's Specialty Pharmacy Services business unit, and the other risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. Readers of this release are referred to the Company's Annual Report on Form 10-K for the year ended December 31, 2002 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2003, for further discussion of these and other factors that could affect future results.

Editors Note: This release is also available on the Internet over the World Wide Web at: www.curative.com.

Contacts

Curative Health Services Scott Eckstein
631/232-7044
seckstein@curativehealth.com

(c) 2003 Business Wire